Alpha 2.0
Login Register
» Articles » PMID: 23562924

Fine Tuning Risk Stratification for Atrial Fibrillation

Overview
Journal J Am Coll Cardiol
Specialty Cardiology & Vascular Diseases
Date 2013 Apr 9
PMID 23562924
Citations 5
Authors
Richard W Troughton
Ian Crozier
Affiliations
Soon will be listed here.
Citing Articles

Unveiling the Molecular Links Between Atrial Fibrillation and Atherosclerosis: Insights into Shared Pathogenesis and Ferroptosis Diagnostic Biomarkers.

Xu B, Li H, Chen H, Teng D, Gong L, Zhong L J Inflamm Res. 2024; 17:8813-8830.

PMID: 39559400 PMC: 11570537. DOI: 10.2147/JIR.S488288.

Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.

Hammersley D, Signy M Ther Adv Chronic Dis. 2017; 8(12):165-176.

PMID: 29201334 PMC: 5692140. DOI: 10.1177/2040622317720106.

Influence of Inflammation and Atherosclerosis in Atrial Fibrillation.

da Silva R Curr Atheroscler Rep. 2017; 19(1):2.

PMID: 28102478 DOI: 10.1007/s11883-017-0639-0.

New Oral Anticoagulants in Nonvalvular Atrial Fibrillation.

Urooj F, Kulkarni A, Stapleton D, Kaluski E Clin Cardiol. 2016; 39(12):739-746.

PMID: 27716952 PMC: 6490750. DOI: 10.1002/clc.22582.

Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: a community-based study.

Nakamura M, Koeda Y, Tanaka F, Onoda T, Itai K, Ohsawa M PLoS One. 2013; 8(12):e81243.

PMID: 24312541 PMC: 3847049. DOI: 10.1371/journal.pone.0081243.